Full-Time

Statistical Science Director

Confirmed live in the last 24 hours

Deadline 6/20/25
AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Senior, Expert

Mississauga, ON, Canada

Employees are required to work in the office 3 days a week.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • MSc/PhD in Statistics, Mathematics (with a substantial statistical component), or a recognized equivalent to a stats MSc.
  • Proven track record of independent leadership.
  • Extensive experience in clinical trials critical for this role.
  • Recognized for exemplary technical skills and expert leadership role or national recognition as a statistical technical expert.
  • Demonstrated ability to provide cross-study support, overseeing, aligning, and providing technical support for multiple studies.
Responsibilities
  • Lead the statistical design and strategy to product development plans, preclinical studies, regulatory strategy, health technology assessment, and/or commercial activities as appropriate for the stage of the product.
  • Lead the statistical content and ensure quality for study designs, documents, delivery, interpretation, and submission.
  • Quantify the benefit, risk, value, and uncertainty of the emerging product profile and communicate these effectively within the team.
  • Provide global leadership to others and direct project work delivered by internal and external staff.
  • Partner with CROs to ensure delivery to quality and time.
  • Represent AstraZeneca externally which may include health authorities, advisory boards, conferences, workshops, and/or payer interactions.
  • Maintain knowledge of statistical methodology in relevant areas and promote, investigate, and implement novel statistical approaches.
  • Represent statistical strategy and decision-making at internal governance including review boards, therapy area leadership teams, and ESPC/LSPC.
  • Mentor/coach and support the technical education and training of Statistics staff.
Desired Qualifications
  • Experience in Vaccines is a strong asset but open to other therapeutic areas (TA).
  • Experience with business development opportunities, such as in-licensing, would be beneficial.
  • Proficiency in programming languages such as SAS, R, and Python.
  • Strong project management skills.
  • Excellent communication skills, especially in relation to project management, ensuring effective cross-functional collaboration and stakeholder engagement.

AstraZeneca develops and sells prescription medicines, focusing on Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Their products are created through extensive research and development, followed by clinical trials and regulatory approvals. Unlike competitors, AstraZeneca emphasizes collaboration through its Open Innovation program and the A.Catalyst Network, which connects health innovation hubs worldwide. The company's goal is to advance healthcare by creating effective treatments for serious diseases.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AstraZeneca's partnership with Danaher enhances precision medicine diagnostics development.
  • The new Rockville cell therapy facility boosts AstraZeneca's manufacturing capabilities.
  • AstraZeneca's collaboration with CSPC expands its reach in the Chinese market.

What critics are saying

  • Increased competition in oncology could impact AstraZeneca's market share.
  • Biosimilars in cardiovascular and respiratory segments may pressure AstraZeneca's pricing.
  • Regulatory changes in the EU and China could delay AstraZeneca's clinical trials.

What makes AstraZeneca unique

  • AstraZeneca's A.Catalyst Network fosters global collaboration and innovation in healthcare.
  • The company invests heavily in R&D to create new drugs and therapies.
  • AstraZeneca's Open Innovation program accelerates drug discovery through shared resources.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Cision
Jun 13th, 2025
Astrazeneca Enters Into Collaboration With Cspc

AstraZeneca enters into collaboration with CSPC

Cision
Jun 6th, 2025
Fixed-Duration Calquence Approved In Eu For 1L Cll

Fixed-duration Calquence approved in EU for 1L CLL

Business Weekly
Jun 5th, 2025
Sortera Bio secures £7.5m pre-seed funding

Sortera Bio, a Cambridge biotech, secured a £7.5m pre-seed round led by Cambridge Innovation Capital, with AstraZeneca and BioNTech participating. The funding will enhance Sortera's Deep Screening platform, which uses AI for drug discovery. Co-founded by Dr. Ben Porebski and Dr. Philipp Holliger, Sortera aims to deliver precision biologics. The technology was developed at the MRC Laboratory of Molecular Biology with AstraZeneca's support.

Pharmashots
Jun 2nd, 2025
AstraZeneca Presents P-III (MATTERHORN) Trial Data of Imfinzi as Perioperative Therapy for G/GEJ Cancers at ASCO 2025

AstraZeneca has shared P-III (MATTERHORN) trial data assessing perioperative Imfinzi + FLOT (n=474) vs PBO + FLOT (n=474) in 948 pts with stage II-IVA G/GEJ cancers at ASCO 2025

Cision
Jun 2nd, 2025
Block Listing Interim Review

2 June 2025 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically and provided to an ris. (Note: Italicised terms have the same meaning as given in the Listing Rules.) Date: 2 June 2025 Name of applicant: ASTRAZENECA PLC Name of scheme: ASTRAZENECA SHARE OPTION PLAN; ASTRAZENECA SAVINGS -RELATED SHARE OPTION PLAN;